Making 'sense' of diabetes: Using a continuous glucose sensor in clinical practice
Authors: Cheyne, E., Kerr, D.
Journal: Diabetes Metabolism Research and Reviews
Publication Date: 30/04/2002
Volume: 18
Issue: SUPPL. 1
Pages: S43-S48
ISSN: 1520-7552
DOI: 10.1002/dmrr.209
Abstract:Home blood glucose monitoring provides only a snapshot picture of prevailing glucose values. Continuous glucose monitoring allows identification of patterns of glucose levels for up to 72 h with details of excursions above and below target levels and thus may be a valuable adjunct tool in diabetes management. We have used the MiniMed Continuous Glucose Monitoring System (CGMS) in ten individuals and have uncovered a significant rate of hypoglycaemia that was previously undetected by conventional means. Preliminary evidence suggests that the novel technology may allow clinicians to 'personalise' intensive insulin therapy with improvement in glycaemic control. Copyright © 2002 John Wiley & Sons, Ltd.
Source: Scopus
Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice.
Authors: Cheyne, E., Kerr, D.
Journal: Diabetes Metab Res Rev
Publication Date: 2002
Volume: 18 Suppl 1
Pages: S43-S48
ISSN: 1520-7552
DOI: 10.1002/dmrr.209
Abstract:Home blood glucose monitoring provides only a snapshot picture of prevailing glucose values. Continuous glucose monitoring allows identification of patterns of glucose levels for up to 72 h with details of excursions above and below target levels and thus may be a valuable adjunct tool in diabetes management. We have used the MiniMed Continuous Glucose Monitoring System (CGMS) in ten individuals and have uncovered a significant rate of hypoglycaemia that was previously undetected by conventional means. Preliminary evidence suggests that the novel technology may allow clinicians to 'personalise' intensive insulin therapy with improvement in glycaemic control.
Source: PubMed
Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice
Authors: Cheyne, E., Kerr, D.
Journal: DIABETES-METABOLISM RESEARCH AND REVIEWS
Publication Date: 2002
Volume: 18
Pages: S43-S48
eISSN: 1520-7560
ISSN: 1520-7552
DOI: 10.1002/dmrr.209
Source: Web of Science
Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice
Authors: Cheyne, E.H., Kerr, D.
Journal: Diabetes/Metabolism Research and Reviews
Publication Date: 2002
Volume: 18
Pages: S43-S48
ISSN: 1520-7552
DOI: 10.1002/dmrr.209
Abstract:Home blood glucose monitoring provides only a snapshot picture of prevailing glucose values. Continuous glucose monitoring allows identification of patterns of glucose levels for up to 72 h with details of excursions above and below target levels and thus may be a valuable adjunct tool in diabetes management. We have used the MiniMed Continuous Glucose Monitoring System (CGMS) in ten individuals and have uncovered a significant rate of hypoglycaemia that was previously undetected by conventional means. Preliminary evidence suggests that the novel technology may allow clinicians to personalise intensive insulin therapy with improvement in glycaemic control.
http://www3.interscience.wiley.com/cgi-bin/abstract/91016184/ABSTRACT?CRETRY=1&SRETRY=0
Source: Manual
Preferred by: David Kerr
Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice.
Authors: Cheyne, E., Kerr, D.
Journal: Diabetes/metabolism research and reviews
Publication Date: 01/2002
Volume: 18 Suppl 1
Pages: S43-S48
eISSN: 1520-7560
ISSN: 1520-7552
DOI: 10.1002/dmrr.209
Abstract:Home blood glucose monitoring provides only a snapshot picture of prevailing glucose values. Continuous glucose monitoring allows identification of patterns of glucose levels for up to 72 h with details of excursions above and below target levels and thus may be a valuable adjunct tool in diabetes management. We have used the MiniMed Continuous Glucose Monitoring System (CGMS) in ten individuals and have uncovered a significant rate of hypoglycaemia that was previously undetected by conventional means. Preliminary evidence suggests that the novel technology may allow clinicians to 'personalise' intensive insulin therapy with improvement in glycaemic control.
Source: Europe PubMed Central